AngioDynamics, Inc. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
AngioDynamics, Inc. (ANGO) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $6.47 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-07-14
- AngioDynamics, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2026 was $6.47M, a 12.41% increase from fiscal 2025.
- AngioDynamics, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $5.76M, a 78.60% decline from fiscal 2024.
- AngioDynamics, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $26.92M, a 384.54% increase from fiscal 2023.
- AngioDynamics, Inc. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $5.56M, a 75.38% increase from fiscal 2022.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month as first filed |
|---|---|---|
| 2026-05-31 | $6.47M 10-K · filed 2026-07-14 | |
| 2025-05-31 | $5.76M 10-K · filed 2026-07-14 | |
| 2024-05-31 | $26.92M 10-K · filed 2026-07-14 | |
| 2023-05-31 | $5.56M 10-K · filed 2025-07-18 | |
| 2022-05-31 | $3.17M 10-K · filed 2024-07-25 | |
| 2021-05-31 | $3.92M 10-K · filed 2023-08-03 | |
| 2020-05-31 | $1.43M 10-K · filed 2022-07-22 | |
| 2019-05-31 | $175.00K 10-K · filed 2021-07-27 | |
| 2018-05-31 | -$18.53M 10-K · filed 2020-08-10 | -$21.74M 10-K · filed 2018-07-23 |
| 2017-05-31 | $2.75M 10-K · filed 2019-07-25 | $6.14M 10-K · filed 2017-08-04 |
| 2016-05-31 | $40.69M 10-K · filed 2018-07-23 | |
| 2015-05-31 | $0.00 10-K · filed 2017-08-04 | |
| 2014-05-31 | $0.00 10-K · filed 2016-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |